Search results
Found 11 matches for
Dr Marco J Haenssgen discusses the application of management thinking to solving the growing global problem of antimicrobial resistance.
Gene associated with better immune response after COVID-19 vaccination identified
News Publications & research news
17 October 2022
Researchers from the Nuffield Department of Medicine have today reported new findings from a study exploring how certain genes can help generate a strong immune response following vaccination with two commonly used COVID-19 vaccines – identifying a particular gene associated with a high antibody response.
Monkeypox can spread widely within specialist hospital isolation rooms
Publications & research news
13 October 2022
A new study found viral monkeypox DNA on multiple surfaces, personal protective equipment, and in air samples in hospital isolation rooms. For some of the samples, the viral particles were capable of replicating and therefore could potentially infect other people.
New computational technique reveals changes to lung function post COVID-19 infection
Publications & research news
4 October 2022
To investigate whether the symptoms of ‘long-COVID’ are associated with any long-term damage that reduces the function of the lungs and respiratory system, a study led by University of Oxford researchers used a novel computational approach to assess how COVID-19 may affect long-term lung function.
Malaria booster vaccine continues to meet WHO-specified 75% efficacy goal
News
8 September 2022
Researchers from the NDM's Jenner Institute and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M™ – which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021.
First clinical trial data for new rabies vaccine candidate demonstrates promising immune response and safety
News Publications & research news
27 July 2022
Researchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the immune response and safety of their newly-developed single shot rabies vaccine, ChAdOx2 RabG.
Largest genetic study of pleural infection reveals complex nature of common disease
News Publications & research news
16 March 2022
A new genetic study of the bacteria that cause pleurisy has shown most cases involve more than one type of bacterium, and revealed which bacterial combinations cause the most serious infections.
RECOVERY trial shows Baricitinib reduces deaths in patients hospitalised with COVID-19
News Publications & research news
3 March 2022
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that baricitinib, an anti-inflammatory treatment normally used to treat rheumatoid arthritis, reduces the risk of death when given to hospitalised patients with severe COVID-19.
Researchers find genetic ‘fingerprints’ of ancient migrations in modern-day United Arab Emirates
News Publications & research news
23 February 2022
A team of geneticists and archaeologists have analysed the fine-scale genetic structure and ancestry of nearly 1200 people from the United Arab Emirates (UAE), and found genetic traces of population mixing spanning thousands of years.
New highly virulent and damaging HIV variant discovered in the Netherlands
News Publications & research news
4 February 2022
A new HIV variant with higher virulence and more damaging health impacts has been discovered in a study led by the University of Oxford.
Uncovering the significance of hypoxia in cancer science
News Publications & research news
4 February 2022
As part of World Cancer Day 2022 we are diving into one of the department's most impactful historical and modern contributions to the field of cancer science and treatment.
Using management thinking to fight the superbug crisis
11 May 2018
Dr Marco J Haenssgen discusses the application of management thinking to solving the growing global problem of antimicrobial resistance.